# A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults

> **NCT02608502** · PHASE3 · COMPLETED · sponsor: **Novavax** · enrollment: 11850 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** RSV-F Vaccine
- **BIOLOGICAL:** Phosphate Buffer Placebo

## Key facts

- **NCT ID:** NCT02608502
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 11850 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608502, "A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02608502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*